Longaeva Partners’s Inspire Medical Systems INSP Stock Holding History

Longaeva Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-138,761	Closed	-$7.16M	–	370
2026 Q1	$7.16M	Buy	+138,761	New	+$9.71M	0.27%	87

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Longaeva Partners's INSP Position: Q2 2026 in Review

Longaeva Partners sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 138,761 shares — an estimated $7.16M sold.

Longaeva Partners first reported a position in INSP in Q1 2026 and held it in 1 quarter. The position peaked at $7.16M in Q1 2026. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Longaeva Partners reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
Longaeva Partners sold 138,761 Inspire Medical Systems shares in Q2 2026, an estimated $7.16M.
Longaeva Partners first reported a position in Inspire Medical Systems in Q1 2026 and held it in 1 quarter.
Longaeva Partners's Inspire Medical Systems position peaked at $7.16M in Q1 2026.
275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.